A recent study marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. As a proof-of-concept, the ...

In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at developing into other cell types, like a younger, fitter version of themselves ...

Your nervous system uses billions of tiny, connected nerve cells called neurons to send ... aim to eat and cook with whole foods that are in their natural state. And cut back on highly processed ...

Surgeons administered either a low or high dose of a stem-cell product from BlueRock Therapeutics, a subsidiary of biotech and pharmaceutical giant Bayer. The treatment was derived from human ...

The new studies took a different approach: They gathered two types of widely available stem cells, turned them into young dopamine neurons, and implanted them into the brain. In one trial, researchers ...

The studies, published April 16 in Nature, represent early steps for stem cell therapies that aim to replace these dead cells in the brain — and stop Parkinson’s and the movement problems ...

Because production of iPS cells doesn’t require the destruction of human embryos ... into four individuals for whom those natural cornea-building stem cells had been depleted — a condition ...

Takebe is Director for Commercial Innovation at Cincinnati Children's Center for Stem ... cell level. But even more research is needed to fully understand how the organoids match up with natural ...

Get Instant Summarized Text (Gist) Two clinical trials confirm the safety of stem cell therapies for Parkinson's disease, using cells from human induced pluripotent and embryonic stem cells. No ...